- Home
- FENC vs NOTE Comparison
FENC vs NOTE Comparison
Compare FENC & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- NOTE
- Stock Information
- Founded
- FENC 1996
- NOTE 2013
- Country
- FENC United States
- NOTE United States
- Employees
- FENC N/A
- NOTE N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- NOTE EDP Services
- Sector
- FENC Health Care
- NOTE Technology
- Exchange
- FENC Nasdaq
- NOTE Nasdaq
- Market Cap
- FENC 156.9M
- NOTE 169.3M
- IPO Year
- FENC 2001
- NOTE N/A
- Fundamental
- Price
- FENC $5.54
- NOTE $1.27
- Analyst Decision
- FENC Strong Buy
- NOTE Strong Buy
- Analyst Count
- FENC 2
- NOTE 6
- Target Price
- FENC $14.00
- NOTE $3.30
- AVG Volume (30 Days)
- FENC 73.5K
- NOTE 4.0M
- Earning Date
- FENC 11-07-2024
- NOTE 03-11-2025
- Dividend Yield
- FENC N/A
- NOTE N/A
- EPS Growth
- FENC N/A
- NOTE N/A
- EPS
- FENC N/A
- NOTE N/A
- Revenue
- FENC $49,348,000.00
- NOTE $125,062,000.00
- Revenue This Year
- FENC $170.43
- NOTE N/A
- Revenue Next Year
- FENC $6.70
- NOTE $4.01
- P/E Ratio
- FENC N/A
- NOTE N/A
- Revenue Growth
- FENC 278.09
- NOTE N/A
- 52 Week Low
- FENC $3.96
- NOTE $0.75
- 52 Week High
- FENC $11.49
- NOTE $2.27
- Technical
- Relative Strength Index (RSI)
- FENC 40.02
- NOTE 55.08
- Support Level
- FENC $5.61
- NOTE $0.98
- Resistance Level
- FENC $6.19
- NOTE $1.37
- Average True Range (ATR)
- FENC 0.26
- NOTE 0.15
- MACD
- FENC -0.10
- NOTE -0.00
- Stochastic Oscillator
- FENC 6.42
- NOTE 53.70
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of global policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With expert analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.